Since 2018, my research has focused on glaucoma pathophysiology investigated by advanced in vitro models. Supported by the A.I.S.G. - Omikron Italia "Marco Centofanti" Research Award, my research group developed a 3D in vitro model of human trabecular meshwork cells to study the conventional aqueous humor outflow pathway, with particular attention to the effects of oxidative stress, mechanical pressure, and pharmacological stimuli. This project consolidated my expertise in millifluidic technologies in 3D cell cultures as tools for investigating cellular dysfunction and toxicity-related mechanisms in ocular tissues. More recently, within a project founded by the Italian Ministry of Health, we are developing retinal organoids derived from human IPSCs aimed at generating retinal ganglion cells (RGCs). These models are designed to study neurodegeneration, cellular vulnerability, and drug-induced effects in glaucoma and related optic neuropathies.
Since 2018, my research has focused on glaucoma pathophysiology investigated by advanced in vitro models. Supported by the A.I.S.G. - Omikron Italia "Marco Centofanti" Research Award, my research group developed a 3D in vitro model of human trabecular meshwork cells to study the conventional aqueous humor outflow pathway, with particular attention to the effects of oxidative stress, mechanical pressure, and pharmacological stimuli. This project consolidated my expertise in millifluidic technologies in 3D cell cultures as tools for investigating cellular dysfunction and toxicity-related mechanisms in ocular tissues. More recently, within a project founded by the Italian Ministry of Health, we are developing retinal organoids derived from human IPSCs aimed at generating retinal ganglion cells (RGCs). These models are designed to study neurodegeneration, cellular vulnerability, and drug-induced effects in glaucoma and related optic neuropathies.